US Patent 10172861 | Patents | Expiry | Expiration | Dates

BAYER HLTHCARE

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LAROTRECTINIB SULFATE

Supporting Information : Click here to upload a PDF

US Patent Number

10172861

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2035-11-16

Patent Use Code

Delist Requested

Application Number

210861

Patent Use Description

Product Number

1

BAYER HLTHCARE

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LAROTRECTINIB SULFATE

Supporting Information : Click here to upload a PDF

US Patent Number

10172861

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2035-11-16

Patent Use Code

Delist Requested

Application Number

210861

Patent Use Description

Product Number

2

BAYER HEALTHCARE

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Germany Flag Germany

Post An Enquiry

Virtual Booth

LAROTRECTINIB SULFATE

Supporting Information : Click here to upload a PDF

US Patent Number

10172861

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2035-11-16

Patent Use Code

Delist Requested

Application Number

211710

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10172861

Bayer HealthCare

BAYER HLTHCARE

LAROTRECTINIB SULFATE

10172861

Y

Y

2035-11-16

210861

1

BAYER HLTHCARE

LAROTRECTINIB SULFATE

10172861

Y

Y

2035-11-16

210861

2

BAYER HEALTHCARE

LAROTRECTINIB SULFATE

10172861

Y

2035-11-16

211710

1